Jimmy Fund Press Releases

2016

Dana-Farber physicians recognized in Boston magazine's 2016 'Top Doctors' issue
December 08, 2016

Boston magazine has named 51 physicians and surgeons affiliated with Dana-Farber Cancer Institute to its annual Top Doctors guide.

Pan-Mass Challenge announces $47 million milestone gift to Dana-Farber Cancer Institute
October 20, 2016

The Pan-Mass Challenge (PMC) today announced a gift of $47 million to support adult and pediatric patient care and cancer research at Dana-Farber.

Ovarian cancer: State of the science
October 03, 2016

Ovarian cancer science - "This is an exciting time for those of us engaged in research and patient care for ovarian cancer."

William G. Kaelin Jr., MD, Dana-Farber researcher, awarded 2016 Lasker Award for Basic Medical Research
September 13, 2016

William G. Kaelin Jr., MD, Dana-Farber researcher, awarded 2016 Lasker Award for Basic Medical Research. The Lasker Award is America's most prestigious biomedical award.

U.S. News & World Report names Dana-Farber/Brigham and Women's Cancer Center the best in the region in cancer
August 02, 2016

U.S. News & World Report names Dana-Farber/Brigham and Women's Cancer Center the best in the region in cancer.

Dana-Farber/Boston Children's remains nation's #1 pediatric cancer program
June 21, 2016

U.S. News & World Report has once again named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the nation's #1 pediatric cancer program in its new 2016-17 Best Children's Hospitals rankings.

ASCO 2016 Update: Immunotherapy and Melanoma
June 15, 2016

As one of the hottest topics in cancer research today, immunotherapy and Dana-Farber took center stage at the 2016 American Society of Clinical Oncology meeting in Chicago.

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma
June 05, 2016

Dual stem-cell transplant improves outlook for children with high-risk neuroblastoma, according to a clinical trial.

New cancer immunotherapy approach combines tumor fighting power with fewer side effects, study shows
May 16, 2016

Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy.

Dana-Farber named one of 100 Great Hospitals in America for 2016
May 08, 2016

Dana-Farber Cancer Institute has been named to Becker's Hospital Review’s 2016 list of "100 Great Hospitals in America."

Dana-Farber and Fitbit partner to test if weight loss can prevent breast cancer recurrence
April 27, 2016

Dana-Farber and Fitbit announced a partnership to support a potentially ground-breaking study that investigates the impact of weight loss on breast cancer recurrence.

Larry Lucchino named Chairman of the Jimmy Fund 
April 20, 2016

Dana-Farber Cancer Institute today appointed Larry Lucchino as Chairman of the Jimmy Fund.

FDA approval of Defibrotide brightens outlook for stem cell transplant patients
March 31, 2016

FDA approval of the new drug Defibrotide brightens the outlook for stem cell transplant patients.

Laurie H. Glimcher, MD, named president of Dana-Farber Cancer Institute
February 23, 2016

Laurie H. Glimcher, MD, an internationally recognized immunologist, has been named the next president and CEO of Dana-Farber Cancer Institute.

Dana-Farber Cancer Institute and Lifespan Health System seek to form a partnership in Rhode Island
February 18, 2016

Dana-Farber Cancer Institute and Lifespan Health System will form a partnership in Rhode Island. The shared goal is to advance cancer care in the region.

Genetic cause identified in rare pediatric brain tumor
February 01, 2016

Researchers found a way of differentiating rare pediatric brain tumors and developed a pathological test that will help children avoid unnecessary and potentially damaging additional therapies.

Scientists discover important genetic source of human diversity
January 25, 2016

Dana-Farber Cancer Institute scientists discover an important genetic source of human diversity.

The Resolution by PMC offers New Year's cyclists new spin on Pan-Mass Challenge
January 11, 2016

The Resolution by PMC, the first indoor cycling event from the Pan-Mass Challenge (PMC), was held at The Club by George Foreman III in the Seaport District on January 2 and 3.

New breakthrough cancer treatments top 2015 Dana-Farber highlights
January 04, 2016

New treatments for leukemia, colorectal cancer, brain cancer, lung cancer and breast cancer topped the list of most important research and clinical developments at Dana-Farber in 2015.

Sign up for updates ›